Ontrak, Inc. (OTRKP)
- Previous Close
0.0000 - Open
0.2221 - Bid 0.2221 x 800
- Ask 0.2500 x 1000
- Day's Range
0.2221 - 0.2221 - 52 Week Range
0.1272 - 0.6175 - Volume
200 - Avg. Volume
2,798 - Market Cap (intraday)
-- - Beta (5Y Monthly) 2.31
- PE Ratio (TTM)
-- - EPS (TTM)
-2.8430 - Earnings Date May 20, 2025 - May 24, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Feb 14, 2022
- 1y Target Est
--
Ontrak, Inc. operates as a value-based behavioral healthcare company in the United States. The company's program predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care and treatment they need. Its technology-enabled solutions are designed to provide healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The company's solution includes Wholehealth+ that enables identifying, engaging, and treating these members through its technology-enabled program that focuses on the intersection between behavioral health, physical health, and social health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. is headquartered in Miami, Florida.
ontrakhealth.com104
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: OTRKP
View MorePerformance Overview: OTRKP
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OTRKP
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OTRKP
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-235.01%
Return on Assets (ttm)
-53.46%
Return on Equity (ttm)
-211.17%
Revenue (ttm)
10.85M
Net Income Avi to Common (ttm)
-79.02M
Diluted EPS (ttm)
-2.8430
Balance Sheet and Cash Flow
Total Cash (mrq)
5.71M
Total Debt/Equity (mrq)
95.25%
Levered Free Cash Flow (ttm)
-12.35M